Modeling the metabolic effects of terbutaline in β2- adrenergic receptor diplotypes

Clinical Pharmacology and Therapeutics

Volumn 76, Issue 1, 2004, Pages 27-37

  Lima, John J ^a   Matsushima, Nobuko ^b   Kissoon, Niranjan ^b   Wang, Jianwei ^b   Sylvester, James E ^b   Jusko, William J ^b  

^a NEMOURS CHILDREN S CLINIC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; GLUCOSE; INSULIN; POTASSIUM; TERBUTALINE;

ACCURACY; ADULT; ANTHROPOMETRY; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; EXPERIMENTAL MODEL; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HOMOZYGOSITY; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INSULIN SYNTHESIS; MALE; MULTIVARIATE ANALYSIS OF COVARIANCE; NORMAL HUMAN; PHARMACODYNAMICS; PHARMACOGENETICS; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; STATISTICAL MODEL;

ADOLESCENT; ADULT; BLOOD GLUCOSE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HAPLOTYPES; HUMANS; INSULIN; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RECEPTORS, ADRENERGIC, BETA-2; TERBUTALINE;

EID: 3042559890     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2004.03.006     Document Type: Article

References (37)

1. Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia. 43:2000;533-549
2. Rizza R.A., Haymond M.W., Cryer P.E., Gerich J.E. Differential effects of epinephrine on glucose production and disposal in man. Am J Physiol Endocrinol Metab Gastrointest Physiol. 237:1979;E356-362
3. Sacca L., Morrone G., Cicala M., Corso G., Ungaro B. Influence of epinephrine, norepinephrine, and isoproterenol on glucose homeostasis in normal man. J Clin Endocrinol Metab. 50:1980;680-684
4. Kawai Y., Powell A., Arinze I.J. Adrenergic receptors in human liver plasma membranes predominance of beta 2- and alpha 1-receptor subtypes. J Clin Endocrinol Metab. 62:1986;827-832
5. Chu C.A., Sindelar D.K., Igawa K., Sherck S., Neal D.W., Emshwiller M., et al. The direct effects of catecholamines on hepatic glucose production occur via alpha(1)- and beta(2)-receptors in the dog. Am J Physiol Endocrinol Metab. 279:2000;E463-473
6. Connolly C.C., Steiner K.E., Stevenson R.W., Neal D.W., Williams P.E., Alberti K.G., et al. Regulation of glucose metabolism by norepinephrine in conscious dogs. Am J Physiol. 261:(6 Pt 1):1991;E764-772
7. Chu C.A., Sindelar D.K., Neal D.W., Allen E.J., Donahue E.P., Cherrington A.D. Comparison of the direct and indirect effects of epinephrine on hepatic glucose production. J Clin Invest. 99:1997;1044-1056
8. Drysdale C.M., McGraw D.W., Stack C.B., Stephens J.C., Judson R.S., Nandabalan K., et al. Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci U S A. 97:2000;10483-10488
9. 2-adrenoceptor haplotypes by denaturation selective amplification and subtractive genotyping. Am J Pharmacogenomics. 1:2001;1175-2203
10. Dishy V., Sofowora G.G., Xie H.G., Kim R.B., Byrne D.W., Stein C.W., et al. The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med. 345:2001;1030-1035
11. 2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med. 158:1998;787-791
12. D'amato M., Vitiani L.R., Petrelli G., Ferrigno L., di Pietro A., Trezza R., et al. Association of persistent bronchial hyperresponsiveness with beta2-adrenoceptor (ADRB2) haplotypes. A population study. Am J Respir Crit Care Med. 158:1998;1968-1973
13. Ulbrecht M., Hergeth M.T., Wjst M., Heinrich J., Bickeboller H., Wichmann H.E., et al. Association of beta(2)-adrenoreceptor variants with bronchial hyperresponsiveness. Am J Respir Crit Care Med. 161:(2 Pt 1):2000;469-474
14. Herring V.L., Johnson J.A. Simple method for determination of terbutaline plasma concentration by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl. 741:2000;307-312
15. Gabrielsson J, Weiner D, editors. Modeling strategies. In: Pharmacokinetic and pharmacodynamic data analysis: concepts and applications. Stockholm: Swedish Pharmaceutical Press; 1997. p. 251-319
16. Gibaldi M., Perrier D. Pharmacokinetics. 1975;Marcel Dekker, Inc, Sydney
17. Jusko W.J., Ko H.C. Physiologic indirect response models characterize diverse types of pharmacodynamic effects. Clin Pharmacol Ther. 56:1994;406-419
18. Ackerman E., Gatewood L.C., Rosevear J.W., Molnar G.D. Model studies of blood-glucose regulation. Bull Math Biophys. 27:(Suppl):1965;21-37
19. Zar J.H. Biostatistical analysis. 2nd ed :1984;Prentice-Hall, Englewood Cliffs
20. Wiethop B.V., Cryer P.E. Glycemic actions of alanine and terbutaline in IDDM. Diabetes Care. 16:1993;1124-1130
21. Hellstrom L., Large V., Reynisdottir S., Wahrenberg H., Arner P. The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and in females. J Intern Med. 245:1999;253-259
22. Ishiyama-Shigemoto S., Yamada K., Yuan X., Ichikawa F., Nonaka K. Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia. 42:1999;98-101
23. Yamada K., Ishiyama-Shigemoto S., Ichikawa F., Yuan X., Koyanagi A., Koyama W., et al. Polymorphism in the 5'-leader cistron of the beta2-adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab. 84:1999;1754-1757
24. Bengtsson K., Orho-Melander M., Melander O., Lindblad U., Ranstam J., Rastam L., et al. Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension. 37:2001;1303-1308
25. Rizza R.A., Cryer P.E., Haymond M.W., Gerich J.E. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest. 65:1980;682-689
26. Clutter W.E., Bier D.M., Shah S.D., Cryer P.E. Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man. J Clin Invest. 66:1980;94-101
27. Philipson L.H. β-Agonists and metabolism. J Allergy Clin Immunol. 110:(Suppl):2002;S313-317
28. Haffner C.A., Kendall M.J., Maxwell S., Hughes B. The lipolytic effect of beta 1- and beta 2-adrenoceptor activation in healthy human volunteers. Br J Clin Pharmacol. 35:1993;35-39
29. Liggett S.B. Polymorphisms of the beta2-adrenergic receptor. N Engl J Med. 346:2002;536-538
30. Rathz D.A., Gregory K.N., Fang Y., Brown K.M., Liggett S.B. Hierarchy of polymorphic variation and desensitization permutations relative to beta 1- and beta 2-adrenergic receptor signaling. J Biol Chem. 278:2003;10784-10789
31. Clausen T. Regulation of active Na+-K+ transport in skeletal muscle. Physiol Rev. 66:1986;542-580
32. Tesfamariam B., Waldron T., Seymour A.A. Quantitation of tremor in response to beta-adrenergic receptor stimulation in primates relationship with hypokalemia. J Pharmacol Toxicol Methods. 40:1998;201-205
33. Moore R.D. Stimulation of Na H exchange by insulin. Biophys J. 33:1981;203-210
34. Robinson R.T., Harris N.D., Ireland R.H., Lee S., Newman C., Heller S.R. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes. 52:2003;1469-1474
35. 2-Adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J. 139:2000;537-542
36. Cockcroft J.R., Gazis A.G., Cross D.J., Wheatley A., Dewar J., Hall I.P., et al. Beta(2)-adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension. 36:2000;371-375
37. 2 Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension. 33:1999;1425-1430